
[Federal Register: September 5, 2008 (Volume 73, Number 173)]
[Notices]               
[Page 51830-51831]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05se08-60]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0450]

 
Science Board to the Food and Drug Administration; Request for 
NominationsSUBJECT>

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is requesting nominations to 
serve on the Science Board to the FDA (Science Board).

[[Page 51831]]

    FDA has special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, encourages nominations qualified 
candidates from these groups.

DATES: Nominations received on or before October 6, 2008 will be given 
first consideration for membership on the Science Board. Nominations 
received after October 6, 2008 will be considered for nomination to the 
Science Board should nominees still be needed.

ADDRESSES: All nomination for membership should be sent electronically 
to CV@OC.FDA.GOV, or by mail to Advisory Committee Oversight & 
Management Staff, 5600 Fishers Lane (HF-4), rm. 15A-12, Rockville, MD 
20857.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership, the primary contact is Carlos Pe[ntilde]a, Office of 
Science and Health Coordination, Office of the Commissioner, Food and 
Drug Administration (HF-33), 5600 Fishers Lane, Rockville, MD 20857, 
301-827-6687, e-mail: carlos.Pe[ntilde]a@fda.hhs.gov. Information about 
becoming a member on a FDA advisory committee can also be obtained by 
visiting FDA's Web site by using the following link http://www.fda.gov/
oc/advisory/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations to the Science 
Board. The Science Board will meet approximately four times a year. 
Meetings of the Science Board will be open to the public. All meetings 
will be announced in the Federal Register at least 15 days prior to 
each scheduled public meeting.

I. General Function of the Committee

    The Science Board shall provide advice primarily to the 
Commissioner and other appropriate officials on specific complex and 
technical issues as well as emerging issues within the scientific 
community. Additionally, the Science Board will provide advice to the 
Agency on keeping pace with technical and scientific evolutions in the 
fields of regulatory science; on formulating an appropriate research 
agenda; and on upgrading its scientific and research facilities to keep 
pace with these changes. It will also provide the means for critical 
review of Agency sponsored intramural and extramural scientific 
research programs.

II. Criteria for Members

    Persons nominated for membership shall be knowledgeable in the 
fields of food safety, nutrition, chemistry, pharmacology, toxicology, 
clinical research, or other scientific disciplines such as systems 
biology, wireless healthcare devices, nanotechnology, medical imaging, 
robotics, cell and tissue based products, regenerative medicine, and 
combination products. Members shall be chosen from academia and 
industry. The Science Board may include one technically qualified 
member, selected by the Commissioner or designee, who is identified 
with consumer interests and is recommended by either a consortium of 
consumer-oriented organizations or other interested persons. The 
Science Board may also include technically qualified Federal members.

III. Nomination Procedures

    Any interested person may nominate one or more qualified person for 
membership on the Science Board. Self nominations are also accepted. 
Nominations shall include the name of the committee, complete 
curriculum vitae of each nominee, and their current business address 
and telephone number and e-mail address if available. Each nomination 
shall state that the nominee is aware of the nomination, is willing to 
serve as a member, and appears to have no conflict of interest that 
would preclude membership. FDA will ask the potential candidates to 
provide detailed information concerning such matters as financial 
holdings, employment, and research grants and/or contracts to permit 
evaluation of possible sources of conflict of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.

    Dated: August 27, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-20574 Filed 9-4-08; 8:45 am]

BILLING CODE 4160-01-S
